[Form 4] OrthoPediatrics Corp. Insider Trading Activity

Rhea-AI Filing Summary

OrthoPediatrics Corp. (KIDS) Form 4: Chief Operating Officer and Chief Financial Officer Fred Hite purchased 5,076 shares of OrthoPediatrics common stock in the open market on 08/21/2025 at $19.41 per share, bringing his beneficial ownership to 213,065 shares including 150,360 restricted shares. The filing notes the purchase was matchable under Section 16(b) with a prior sale, and Mr. Hite disgorged $27,664.20 to the company representing the full short-swing profit.

The transaction was reported by an attorney-in-fact on 08/25/2025. The Form 4 shows direct ownership and does not report derivative transactions. No additional executive departures, changes in compensation, or forward-looking statements are included in the filing.

Insights

Financial Analyst

TL;DR: Insider bought a modest number of shares while resolving a short-swing profit with a disgorgement; impact is likely neutral to investors.

The reported open-market purchase of 5,076 shares at $19.41 is small relative to total outstanding shares and to Mr. Hite's reported 213,065 beneficially owned shares, suggesting limited economic impact on supply or demand. The noted disgorgement of $27,664.20 indicates the prior sale generated a short-swing profit that was returned to the company, which resolves a technical Section 16(b) issue but does not indicate ongoing financial distress. For investors this is a routine insider activity disclosure rather than a material corporate development.

Corporate Governance Expert

TL;DR: Disgorgement for a Section 16(b) matchable transaction raises governance and compliance questions despite remediation.

The filing discloses that the open-market purchase was matchable with a prior sale triggering a short-swing profit under Section 16(b); Mr. Hite returned the full profit of $27,664.20. While the disgorgement closes the immediate compliance matter, it highlights a lapse in transaction timing oversight for a senior officer who serves as COO and CFO. The company should ensure stronger pre-clearance and reporting controls to prevent recurrence. This is governance-relevant but not necessarily material to operations.

Insider Trade Summary

Net Buyer: 5,076 shares

Net Buy 1 txn

Insider Hite Fred

Role COO and CFO

Bought 5,076 shs ($99K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	5,076	$19.41	$99K

Holdings After Transaction: Common Stock — 213,065 shares (Direct)

Footnotes (3)

1. F1. Mr. Hite's purchase of common stock reported herein was matchable under Section 16(b) of the Exchange Act with a previous sale. Mr. Hite has disgorged $27,664.20 to OrthoPediatrics Corp., representing the full amount of profit realized in connection with the short swing transaction.
2. F2. Represents shares that were purchased by Mr. Hite in the open market.
3. F3. Includes restricted stock awards totaling 150,360 shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/25/2025 - 10:24 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hite Fred

(Last) (First) (Middle)

C/O ORTHOPEDIATRICS CORP.

2850 FRONTIER DRIVE

(Street)

WARSAW IN 46582

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ORTHOPEDIATRICS CORP [ KIDS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	COO and CFO

3. Date of Earliest Transaction (Month/Day/Year)
08/21/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/21/2025		P(1)		5,076(2)	A	$19.41	213,065(3)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Mr. Hite's purchase of common stock reported herein was matchable under Section 16(b) of the Exchange Act with a previous sale. Mr. Hite has disgorged $27,664.20 to OrthoPediatrics Corp., representing the full amount of profit realized in connection with the short swing transaction.

2. Represents shares that were purchased by Mr. Hite in the open market.

3. Includes restricted stock awards totaling 150,360 shares.

Remarks:

	/s/ Daniel J. Gerritzen, Attorney-in-Fact	08/25/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.